The Asia Pacific Real World Evidence Solutions Market would witness market growth of 9.0% CAGR during the forecast period (2022-2028).
The major pharmaceutical companies use a clinico-genomic database containing tumor sequencing data for cancer discovery investigations and the development of targeted drugs. As a result, businesses are able to perform a modest number of clinical trials for the uncommon biomarker-defined group while also expanding their range of indications. Thus, it shows that the market for real-world evidence solutions will rise in the coming years.
RWE can add patient-generated data, like biometric data or patient-reported outcomes (PROs), that is simpler to obtain between doctor visits to traditional outcome measurements during clinical studies. RWE is able to monitor quality and result metrics across organizations. For example, RWE can notify administrators of the benchmarking performance of their physicians and the performance of their overall health system compared to others.
This information can improve quality-based reimbursement schemes that honor good results and can assist payers and consumers in having more informed coverage discussions. Clinical registries, like the patient, product, and claims registries, are rich sources of RWD addition to that. They are essential resources for producing RWE and utilizing it to facilitate post-market investigation and surveillance.
Using RWE for regulatory & reimbursement decision-making is a journey that governments and regulators around the Asia Pacific are at various levels of. To show RWE's advantages and capabilities, some have already released formal advice and are moving on with pilot projects. Others are still in the initial phases of those approaches. Due to China's growing need for empirical data to support healthcare decisions, many new data sources have developed. Health economics, epidemiology, and outcomes research have not comprehensively assessed the real-world healthcare data sources that are currently available. Thus, the increased utilization of real world evidence in healthcare sector is driving the growth of Asia Pacific real world evidence solutions market.
The China market dominated the Asia Pacific Real World Evidence Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,657.7 million by 2028.The Japan market is estimated to grow a CAGR of 8.4% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.7% during (2022 - 2028).
Based on Component, the market is segmented into Services and Data Set. Based on Therapeutic Area, the market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory and Others. Based on End-user, the market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers and Others. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making and Post Market Safety & Adverse Events Monitoring. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Real World Evidence Solutions Market is Projected to reach USD 65.1 Billion by 2028, at a CAGR of 8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Component
By Therapeutic Area
- Oncology
- Cardiology
- Neurology
- Diabetes
- Respiratory
- Others
By End-user
- Healthcare Companies
- Healthcare Payers
- Healthcare Providers
- Others
By Application
- Drug Development & Approvals
- Medical Device Development & Approvals
- Reimbursement/Coverage & Regulatory Decision Making
- Post Market Safety & Adverse Events Monitoring
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- IBM Corporation
- Oracle Corporation
- Medpace Holdings, Inc.
- IQVIA Holdings, Inc.
- ICON plc
- PerkinElmer, Inc.
- Parexel International Corporation (Phoenix Parentco, Inc.)
- PPD, Inc. (Thermo Fisher Scientific, Inc.)
- UnitedHealth Group, Inc. (Optum, Inc.)
- Syneos Health, Inc.
TABLE 1 Asia Pacific Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Data Set Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Data Set Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Oncology Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Oncology Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Neurology Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Neurology Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Respiratory Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Respiratory Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Healthcare Companies Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Healthcare Companies Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Drug Development & Approvals Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Drug Development & Approvals Market by Country, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Medical Device Development & Approvals Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Medical Device Development & Approvals Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2022 - 2028, USD Million
TABLE 41 Asia Pacific Post Market Safety & Adverse Events Monitoring Market by Country, 2018 - 2021, USD Million
TABLE 42 Asia Pacific Post Market Safety & Adverse Events Monitoring Market by Country, 2022 - 2028, USD Million
TABLE 43 Asia Pacific Real World Evidence Solutions Market by Country, 2018 - 2021, USD Million
TABLE 44 Asia Pacific Real World Evidence Solutions Market by Country, 2022 - 2028, USD Million
TABLE 45 China Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 46 China Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 47 China Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 48 China Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 49 China Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 50 China Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 51 China Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 52 China Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 53 China Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 54 China Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 55 Japan Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 56 Japan Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 57 Japan Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 58 Japan Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 59 Japan Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 60 Japan Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 61 Japan Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 62 Japan Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 63 Japan Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 64 Japan Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 65 India Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 66 India Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 67 India Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 68 India Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 69 India Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 70 India Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 71 India Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 72 India Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 73 India Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 74 India Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 75 South Korea Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 76 South Korea Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 77 South Korea Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 78 South Korea Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 79 South Korea Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 80 South Korea Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 81 South Korea Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 82 South Korea Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 83 South Korea Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 84 South Korea Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 85 Singapore Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 86 Singapore Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 87 Singapore Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 88 Singapore Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 89 Singapore Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 90 Singapore Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 91 Singapore Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 92 Singapore Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 93 Singapore Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 94 Singapore Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 95 Malaysia Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 96 Malaysia Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 97 Malaysia Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 98 Malaysia Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 99 Malaysia Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 100 Malaysia Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 101 Malaysia Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 102 Malaysia Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 103 Malaysia Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 104 Malaysia Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 105 Rest of Asia Pacific Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 106 Rest of Asia Pacific Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 107 Rest of Asia Pacific Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 108 Rest of Asia Pacific Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 109 Rest of Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 110 Rest of Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 111 Rest of Asia Pacific Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 112 Rest of Asia Pacific Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 113 Rest of Asia Pacific Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 114 Rest of Asia Pacific Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 115 Key information – IBM Corporation
TABLE 116 Key Information – Oracle Corporation
TABLE 117 Key Information – PPD, Inc.
TABLE 118 Key Information – UnitedHealth Group, Inc.
TABLE 119 Key Information – Syneos Health, Inc.
TABLE 120 Key information – IQVIA Holdings, Inc.
TABLE 121 key Information – Medpace Holdings, Inc.
TABLE 122 key Information – PerkinElmer, Inc.
TABLE 123 Key Information – PAREXEL International Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: IBM Corporation
FIG 3 SWOT analysis: Oracle Corporation
FIG 4 Swot analysis: thermo fisher scientific, inc.